Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Progen reports Phase II results for lung cancer
Progen said the overall data from this trial suggests that no further investigation of PI-88 in combination with docetaxel in patients with non small cell lung cancer that
Progen said the overall data from this trial suggests that no further investigation of PI-88 in combination with docetaxel in patients with non small cell lung cancer that
Pharmacopeia will receive a $1 million milestone payment from Schering-Plough as a result of this trial initiation. Les Browne, president and CEO of Pharmacopeia, said: “The Schering-Plough collaboration
Encysive has been discussing possible protocols for the trial, to be called Stride 5, with its scientific advisory board and other experts. The company will now work with
Intronn is known for developing and patenting spliceosome-mediated RNA trans-splicing (SMaRT) technology, a new approach to genetic medicine. SMaRT RNA therapy uses gene therapy vectors to deliver proprietary
InterMune has also granted the underwriters a 30-day option to purchase up to an additional 525,000 shares of common stock. All of the shares in the offering are
The fast track program is designed to facilitate the development and expedite the regulatory review of new drugs that demonstrate the potential to treat serious or life-threatening diseases
The positive opinion for Eucreas was issued by the Committee for Medicinal Products for Human Use (CHMP), which reviews medicines for the European Commission (EC). The recommendation was
The European Commission generally follows the recommendations of the committee for medicinal products for human use (CHMP) and delivers its final decision within three months. The decision will
The study also demonstrated that Levemir provides good glycaemic control in both types of diabetes and reduced rates of hypoglycaemia. Type I diabetes patients treated with Levemir gained
Prostate cancer is claimed to be the most frequently occurring cancer among males in developed countries and accounts for 9% of cancer deaths in men, second only to